Introduction. The @entity5 's ability to metastasize remains one of the major obstacles when treating @entity1 with @entity5 . The indication of metastasectomy is currently limited to @entity1 undergoing treatment of the @entity5 . Resections for lung metastases of high selected @entity1 with @entity5464 present minimal risks and can prolong survival. Prognostic factors that determine which @entity1 will benefit from surgery are still unclear. Material and results. This article presents a retrospective analysis of @entity1 who underwent lung metastases resection between 2008 and 2013 in our clinic. Among 148 @entity1 , 8 (5.41%) had lung metastases after @entity5 ( @entity5 ), 18 (12.16%) after @entity5 ( @entity5 ), 13 (8.78%) after @entity0 and 109 (73.65%) had lung metastases from other type of @entity5 . The overall 6 months survival was 100% for @entity5 , 94.44 for @entity5 , 84.62% for BC and 87.16% for others. Discussion and conclusion. The criteria for surgery proved to have a positive predictive value and what should be considered are the following: prolonged disease-free interval (DFI), unilateral disease, the absence of systemic pathologies, oncological margins resecability and less than 3 radioimagistic detectable metastases. A negative prognosis was observed in those with @entity5 in the cervix, at least 3 metastases and a @entity5 larger than 3 cm. To determine how to select surgical candidates for pulmonary metastasectomy more precisely, further analysis of prognostic factors is evident and the need for a prospective, randomized, multicenter study is clear.

Surgical treatment for pulmonary metastases in XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'urologic cancers', 'UC', 'malignant disease', 'genital cancers', 'GC', 'cancer', 'primary tumor', 'tumors'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity5464 :: ('MESH:D014565', 'Disease') :: ['urogenital cancer'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast tumors']
@entity5464 :: (MESH:D014565,Disease) :: ['urogenital cancers']
